Adenoviral MUC1 vaccine (Etubics)

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameAdenoviral MUC1 vaccine (Etubics)
Drug Alias NameAdenoviral MUC1 vaccine - EtubicsETBX-061Ad5-MUC1
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsMucin-1 modulators
TargetsMucin-1
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[18] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEtubics CorpImmunitybio IncNantkwest Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunitybio IncNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungLung Neoplasms +[18] 

Other Information

ATC CodeN/A
Related LinksN/A